Chemotherapy remains the cornerstone (gemcitabine, FOLFIRINOX, nab‑paclitaxel), with radiation, targeted therapy, and immunotherapy expanding in usage https://www.datamintelligence.com/research-report/north-america-locally-advanced-pancreatic-cancer-market